Long-term somatic side-effects and morbidity in testicular cancer patients

54Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In order to evaluate long-term somatic morbidity after treatment for testicular cancer 149 patients with NED ≥ 3 years answered a questionnaire. The patients had been treated with surgery only (32 patients), radiotherapy only (39 patients), cisplatin-based chemotherapy plus surgery (46 patients) or chemotherapy plus radiotherapy with or without surgery (32 patients). Raynaud-like phenomena were the most frequent side- effect occurring significantly more often after cisplatin-based chemotherapy than after surgery or radiotherapy (33/72 patients versus 5/68 patients). Peripheral sensory ‘neuropathy’ was reported by 18% of all the patients. Seventeen per cent and 11% complained of pulmonary symptoms and auditory symptoms, respectively. Gastrointestinal side-effects were more frequent after any type of cytotoxic therapy than after surgery only (34/47 patients versus 5/22 patients). Twenty-six patients had fathered children after treatment. About 80% of the patients were in full time wage-earning activity when they answered the questionnaire. In conclusion, 3-7 years after treatment for testicular cancer, 30-50% of the patients had minor somatic complaints whereas serious side-effects seldom occurred. © Macmillan Press Ltd., 1990.

Cite

CITATION STYLE

APA

Aass, N., Kaasa, S., Lund, E., Kaalhus, O., Heier, M. S., & Fosså, S. D. (1990). Long-term somatic side-effects and morbidity in testicular cancer patients. British Journal of Cancer, 61(1), 151–155. https://doi.org/10.1038/bjc.1990.31

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free